<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37115004</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Cytoplasmic aggregation of mutant FUS causes multistep RNA splicing perturbations in the course of motor neuron pathology.</ArticleTitle><Pagination><StartPage>5810</StartPage><EndPage>5830</EndPage><MedlinePgn>5810-5830</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkad319</ELocationID><Abstract><AbstractText>Dysfunction of the RNA-binding protein (RBP) FUS implicated in RNA metabolism can cause amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Mutations affecting FUS nuclear localization can drive RNA splicing defects and stimulate the formation of non-amyloid inclusions in affected neurons. However, the mechanism by which FUS mutations contribute to the development of ALS remains uncertain. Here we describe a pattern of RNA splicing changes in the dynamics of the continuous proteinopathy induced by mislocalized FUS. We show that the decrease in intron retention of FUS-associated transcripts represents the hallmark of the pathogenesis of ALS and is the earliest molecular event in the course of progression of the disease. As FUS aggregation increases, the pattern of RNA splicing changes, becoming more complex, including a decrease in the inclusion of neuron-specific microexons and induction of cryptic exon splicing due to the sequestration of additional RBPs into FUS aggregates. Crucially, the identified features of the pathological splicing pattern are also observed in ALS patients in both sporadic and familial cases. Our data provide evidence that both a loss of nuclear FUS function due to mislocalization and the subsequent cytoplasmic aggregation of mutant protein lead to the disruption of RNA splicing in a multistep fashion during FUS aggregation.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rezvykh</LastName><ForeName>Alexander P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, 119991, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ustyugov</LastName><ForeName>Aleksey A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry of Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaprov</LastName><ForeName>Kirill D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry of Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teterina</LastName><ForeName>Ekaterina V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry of Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nebogatikov</LastName><ForeName>Vladimir O</ForeName><Initials>VO</Initials><AffiliationInfo><Affiliation>Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry of Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spasskaya</LastName><ForeName>Daria S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, 119991, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evgen'ev</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, 119991, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morozov</LastName><ForeName>Alexey V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, 119991, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funikov</LastName><ForeName>Sergei Yu</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0002-3336-6119</Identifier><AffiliationInfo><Affiliation>Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, 119991, Russian Federation.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>18-74-10095</GrantID><Agency>Russian Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012326" MajorTopicYN="N">RNA Splicing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37115004</ArticleId><ArticleId IdType="pmc">PMC10287951</ArticleId><ArticleId IdType="doi">10.1093/nar/gkad319</ArticleId><ArticleId IdType="pii">7146345</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xue Y.C., Ng C.S., Xiang P., Liu H., Zhang K., Mohamud Y., Luo H.. Dysregulation of RNA-binding proteins in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2020; 13:78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273501</ArticleId><ArticleId IdType="pubmed">32547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone B., La&#xa0;Cognata V., Sprovieri T., Ungaro C., Conforti F.L., And&#xf2; S., Cavallaro S.. Alternative splicing of ALS genes: misregulation and potential therapies. Cell. Mol. Neurobiol. 2020; 40:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31385134</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A.. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2018; 9:712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De&#xa0;Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P.et al. .. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009; 323:1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E.et al. .. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008; 319:1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Zupunski V., Troakes C., Kathe C., Fratta P., Howell M., Gallo J.M., Hortob&#xe1;gyi T., Shaw C.E., Rogelj B.. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain. 2010; 133:1763&#x2013;1771.</Citation><ArticleIdList><ArticleId IdType="pubmed">20472655</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R., Capell A., Schmid B.et al. .. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010; 29:2841&#x2013;2857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiihashi G., Ito D., Yagi T., Nihei Y., Ebine T., Suzuki N.. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain. 2016; 139:2380&#x2013;2394.</Citation><ArticleIdList><ArticleId IdType="pubmed">27368346</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sendscheid O., El&#xa0;Oussini H., Jambeau M., Sun Y., Mersmann S., Wagner M., Dieterl&#xe9; S., Sinniger J., Dirrig-Grosch S.et al. .. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016; 35:1077&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H., Lee S., Shang Y., Wang W.Y., Au K.F., Kamiya S., Barmada S.J., Finkbeiner S., Lui H., Carlton C.E.et al. .. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 2014; 124:981&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Peters O.M., Deykin A.V., Connor-Robson N., Robinson H., Ustyugov A.A., Bachurin S.O., Ermolkevich T.G., Goldman I.L., Sadchikova E.R.et al. .. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J. Biol. Chem. 2013; 288:25266&#x2013;25274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3757190</ArticleId><ArticleId IdType="pubmed">23867462</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.F., Gendron T.F., Zhang Y.J., Lin W.L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X.et al. .. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 2010; 30:10851&#x2013;10859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H., Kleinberger G., Janssens J., Pereson S., Joris G., Cuijt I., Smits V., Ceuterick-de&#xa0;Groote C., Van&#xa0;Broeckhoven C., Kumar-Singh S.. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA. 2010; 107:3858&#x2013;3863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Kocerha J., Finch N., Crook R., Baker M., Desaro P., Johnston A., Rutherford N., Wojtas A., Kennelly K.et al. .. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum. Mutat. 2010; 31:E1377&#x2013;E1389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922682</ArticleId><ArticleId IdType="pubmed">20232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Zhai H., Bigio E.H., Yan J., Fecto F., Ajroud K., Mishra M., Ajroud-Driss S., Heller S., Sufit R.et al. .. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 2010; 67:739&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4376270</ArticleId><ArticleId IdType="pubmed">20517935</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M.et al. .. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Litscher G., Watanabe N., Wei W., Hashimoto T., Iwatsubo T., Buchman V.L., Shelkovnikova T.A.. ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity. Neurobiol. Dis. 2022; 162:105585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8799889</ArticleId><ArticleId IdType="pubmed">34915152</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Koppers M., Groen E.J.N., van&#xa0;den&#xa0;Heuvel D.M.A., Dini&#xa0;Modigliani S., Anink J.J., Fumoto K., van&#xa0;Diggelen F., Snelting A., Sodaar P.et al. .. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 2016; 132:175&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Arenas A., Zhai J., Zhu H., Gal J.. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim. Biophys. Acta. 2016; 1862:2004&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Ling S.C., Qiu J., Albuquerque C.P., Zhou Y., Tokunaga S., Li H., Qiu H., Bui A., Yeo G.W.et al. .. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 2015; 6:6171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Jiang X., Chen G., Xu J.. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways. Neurobiol. Aging. 2015; 36:527&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">25192599</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E.S., Ling S.C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A.et al. .. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl Acad. Sci. USA. 2013; 110:E736&#x2013;E745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Highley J.R., Kirby J., Jansweijer J.A., Webb P.S., Hewamadduma C.A., Heath P.R., Higginbottom A., Raman R., Ferraiuolo L., Cooper-Knock J.et al. .. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol. Appl. Neurobiol. 2014; 40:670&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">24750229</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Birsa N., Milioto C., McLaughlin M., Ule A.M., Robaldo D., Eberle A.B., Kr&#xe4;uchi R., Bentham M., Brown A.L.et al. .. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 2020; 48:6889&#x2013;6905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Taguchi R., Deguchi M., Ogasawara H., Inoue E.. Extensive splicing changes in an ALS/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma. Sci. Rep. 2020; 10:4857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078223</ArticleId><ArticleId IdType="pubmed">32184412</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjuan-Ruiz I., Govea-Perez N., McAlonis-Downes M., Dieterle S., Megat S., Dirrig-Grosch S., Picchiarelli G., Piol D., Zhu Q., Myers B.et al. .. Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation. Mol. Neurodegener. 2021; 16:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419956</ArticleId><ArticleId IdType="pubmed">34488813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S., Liu G., Ozt&#xfc;rk A., Hicks G.G.. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013; 9:e1003895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoy A., Kalmar B., Stewart M., Park H., Burke B., Noy S.J., Redhead Y., Humphrey J., Lo K., Jaeger J.et al. .. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14' knockin mice. Brain. 2017; 140:2797&#x2013;2805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841203</ArticleId><ArticleId IdType="pubmed">29053787</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J.N., Artates J., Bui A.T., Vetto A.P.et al. .. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018; 100:816&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A.. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016; 7:10465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaprov K., Rezvykh A., Funikov S., Ivanova T.A., Lysikova E.A., Deykin A.V., Kukharsky M.S., Yu&#xa0;Aksinenko A., Bachurin S.O., Ninkina N.et al. .. A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice. CNS Neurosci. Ther. 2021; 27:765&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193697</ArticleId><ArticleId IdType="pubmed">33754495</ArticleId></ArticleIdList></Reference><Reference><Citation>Funikov S.Y., Rezvykh A.P., Mazin P.V., Morozov A.V., Maltsev A.V., Chicheva M.M., Vikhareva E.A., Evgen&#x2019;ev M.B., Ustyugov A.A.. FUS(1&#x2013;359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics. 2018; 19:189&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">29982879</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Belzil V.V., Batra R., Ross C.A., Gendron T.F., Pregent L.J., Murray M.E., Overstreet K.K., Piazza-Johnston A.E., Desaro P.et al. .. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015; 18:1175&#x2013;1182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Gonzales P.K., Cook C.N., Gendron T.F., Daughrity L.M., Song Y., Ebbert M.T.W., van&#xa0;Blitterswijk M., Zhang Y.J., Jansen-West K.et al. .. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients. Hum. Mol. Genet. 2017; 26:3421&#x2013;3431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886204</ArticleId><ArticleId IdType="pubmed">28637276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Pratt G.A., Vu A.Q., Hutt K.R., Martinez F.J., Sundararaman B., Batra R., Freese P., Lambert N.J., Huelga S.C.et al. .. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016; 7:12143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., Wainger B.J., Han S., Peng T., Thams S., Mikkilineni S.et al. .. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014; 14:781&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F., Batra R., Wheeler E.C., Vu A.Q., Wang R., Hutt K., Rabin S.J., Baughn M.W., Libby R.T., Diaz-Garcia S.et al. .. Transcriptome&#x2013;pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018; 136:405&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Paggi J.M., Park C., Bennett C., Salzberg S.L.. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 2019; 37:907&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazin P.V., Khaitovich P., Cardoso-Moreira M., Kaessmann H.. Alternative splicing during mammalian organ development. Nat. Genet. 2021; 53:925&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8187152</ArticleId><ArticleId IdType="pubmed">33941934</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R.. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25:2078&#x2013;2079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazin P., Xiong J., Liu X., Yan Z., Zhang X., Li M., He L., Somel M., Yuan Y., Phoebe&#xa0;Chen Y.P.et al. .. Widespread splicing changes in human brain development and aging. Mol. Syst. Biol. 2013; 9:633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3564255</ArticleId><ArticleId IdType="pubmed">23340839</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia M., Weatheritt R.J., Ellis J.D., Parikshak N.N., Gonatopoulos-Pournatzis T., Babor M., Quesnel-Valli&#xe8;res M., Tapial J., Raj B., O&#x2019;Hanlon D.et al. .. A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell. 2014; 159:1511&#x2013;1523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4390143</ArticleId><ArticleId IdType="pubmed">25525873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira J.A. The Benjamini&#x2013;Hochberg method in the case of discrete test statistics. Int. J. Biostat. 2007; 3:11.</Citation><ArticleIdList><ArticleId IdType="pubmed">22550651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002; 12:996&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC186604</ArticleId><ArticleId IdType="pubmed">12045153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard K.S., Hubisz M.J., Rosenbloom K.R., Siepel A.. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010; 20:110&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798823</ArticleId><ArticleId IdType="pubmed">19858363</ArticleId></ArticleIdList></Reference><Reference><Citation>Team, R.C. R: A Language and Environment for Statistical Computing. 2021; R Foundation for Statistical Computing.</Citation></Reference><Reference><Citation>Wickham H. ggplot2: Elegant Graphics for Data Analysis. 2016; NY: Springer-Verlag.</Citation></Reference><Reference><Citation>Constantin A., I Patil.. ggsignif: r Package for Displaying Significance Brackets. 2021; PsyArXiv doi:31 March 2021, preprint: not peer reviewed10.31234/osf.io/7awm6.</Citation><ArticleIdList><ArticleId IdType="doi">10.31234/osf.io/7awm6</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorvaldsd&#xf3;ttir H., Robinson J.T., Mesirov J.P.. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Briefings Bioinf. 2013; 14:178&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3603213</ArticleId><ArticleId IdType="pubmed">22517427</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Smyth G.K., Shi W.. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013; 41:e108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664803</ArticleId><ArticleId IdType="pubmed">23558742</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M.D., McCarthy D.J., Smyth G.K.. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010; 26:139&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M.D., Oshlack A.. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010; 11:R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864565</ArticleId><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathyamurthy A., Johnson K.R., Matson K.J.E., Dobrott C.I., Li L., Ryba A.R., Bergman T.B., Kelly M.C., Kelley M.W., Levine A.J.. Massively parallel single nucleus transcriptional profiling defines spinal cord neurons and their activity during behavior. Cell Rep. 2018; 22:2216&#x2013;2225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5849084</ArticleId><ArticleId IdType="pubmed">29466745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman B.T., Hao M., Qiu J., Jiao X., Baseler M.W., Lane H.C., Imamichi T., Chang W.. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022; 50:W216&#x2013;W221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252805</ArticleId><ArticleId IdType="pubmed">35325185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge S.X., Jung D., Yao R.. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020; 36:2628&#x2013;2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7178415</ArticleId><ArticleId IdType="pubmed">31882993</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G. Gene Ontology semantic similarity analysis using GOSemSim. Methods Mol. Biol. 2020; 2117:207&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">31960380</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathan M., Keerthikumar S., Ang C.S., Gangoda L., Quek C.Y., Williamson N.A., Mouradov D., Sieber O.M., Simpson R.J., Salim A.et al. .. FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015; 15:2597&#x2013;2601.</Citation><ArticleIdList><ArticleId IdType="pubmed">25921073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence M., Huber W., Pag&#xe8;s H., Aboyoun P., Carlson M., Gentleman R., Morgan M.T., Carey V.J.. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 2013; 9:e1003118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738458</ArticleId><ArticleId IdType="pubmed">23950696</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo G., Burge C.B.. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 2004; 11:377&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">15285897</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey T.L. STREME: accurate and versatile sequence motif discovery. Bioinformatics. 2021; 37:2834&#x2013;2840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8479671</ArticleId><ArticleId IdType="pubmed">33760053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey T.L., Johnson J., Grant C.E., Noble W.S.. The MEME Suite. Nucleic Acids Res. 2015; 43:W39&#x2013;W49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4489269</ArticleId><ArticleId IdType="pubmed">25953851</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Stamatoyannopoulos J.A., Bailey T.L., Noble W.S.. Quantifying similarity between motifs. Genome Biol. 2007; 8:R24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1852410</ArticleId><ArticleId IdType="pubmed">17324271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray D., Kazan H., Cook K.B., Weirauch M.T., Najafabadi H.S., Li X., Gueroussov S., Albu M., Zheng H., Yang A.et al. .. A compendium of RNA-binding motifs for decoding gene regulation. Nature. 2013; 499:172&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929597</ArticleId><ArticleId IdType="pubmed">23846655</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R.. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013; 29:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan A.R., Hall I.M.. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010; 26:841&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2832824</ArticleId><ArticleId IdType="pubmed">20110278</ArticleId></ArticleIdList></Reference><Reference><Citation>Uren P.J., Bahrami-Samani E., Burns S.C., Qiao M., Karginov F.V., Hodges E., Hannon G.J., Sanford J.R., Penalva L.O., Smith A.D.. Site identification in high-throughput RNA&#x2013;protein interaction data. Bioinformatics. 2012; 28:3013&#x2013;3020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3509493</ArticleId><ArticleId IdType="pubmed">23024010</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G., Wang L.G., He Q.Y.. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015; 31:2382&#x2013;2383.</Citation><ArticleIdList><ArticleId IdType="pubmed">25765347</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner N. Chi-squared test. J. Clin. Nurs. 2000; 9:93.</Citation><ArticleIdList><ArticleId IdType="pubmed">11041649</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., Simonovic M., Doncheva N.T., Morris J.H., Bork P.et al. .. STRING v11: protein&#x2013;protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019; 47:D607&#x2013;D613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T.. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13:2498&#x2013;2504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Dastidar S.G., Tokunaga S., Ho W.Y., Lim K., Ilieva H., Parone P.A., Tyan S.H., Tse T.M., Chang J.C.et al. .. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy&#x2013;lysosome axis. Elife. 2019; 8:e40811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Robinson H.K., Southcombe J.A., Ninkina N., Buchman V.L.. Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms. Hum. Mol. Genet. 2014; 23:5211&#x2013;5226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159159</ArticleId><ArticleId IdType="pubmed">24842888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C.et al. .. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012; 15:1488&#x2013;1497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvinge H., Bradley R.K.. Widespread intron retention diversifies most cancer transcriptomes. Genome Med. 2015; 7:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4480902</ArticleId><ArticleId IdType="pubmed">26113877</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz U., Pinello N., Jia F., Alasmari S., Ritchie W., Keightley M.C., Shini S., Lieschke G.J., Wong J.J., Rasko J.E.J.. Intron retention enhances gene regulatory complexity in vertebrates. Genome Biol. 2017; 18:216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5688624</ArticleId><ArticleId IdType="pubmed">29141666</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen E.J., Fumoto K., Blokhuis A.M., Engelen-Lee J., Zhou Y., van&#xa0;den&#xa0;Heuvel D.M., Koppers M., van&#xa0;Diggelen F., van&#xa0;Heest J., Demmers J.A.et al. .. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum. Mol. Genet. 2013; 22:3690&#x2013;3704.</Citation><ArticleIdList><ArticleId IdType="pubmed">23681068</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T., Michel C.H.et al. .. ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015; 88:678&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Bampton A., Gatt A., Humphrey J., Cappelli S., Bhattacharya D., Foti S., Brown A.L., Asi Y., Low Y.H., Foiani M.et al. .. HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing. Acta Neuropathol. 2021; 142:609&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423707</ArticleId><ArticleId IdType="pubmed">34274995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bampton A., Gittings L.M., Fratta P., Lashley T., Gatt A.. The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis. Acta Neuropathol. 2020; 140:599&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547044</ArticleId><ArticleId IdType="pubmed">32748079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J.P., Chhabra R., Merran J.D., Schaughency P.M., Wheelan S.J., Corden J.L., Wong P.C.. PTBP1 and PTBP2 repress nonconserved cryptic exons. Cell Rep. 2016; 17:104&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5082185</ArticleId><ArticleId IdType="pubmed">27681424</ArticleId></ArticleIdList></Reference><Reference><Citation>McClory S.P., Lynch K.W., Ling J.P.. HnRNP L represses cryptic exons. RNA. 2018; 24:761&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959245</ArticleId><ArticleId IdType="pubmed">29581412</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q., Yalamanchili H.K., Park J., De&#xa0;Maio A., Lu H.C., Wan Y.W., White J.J., Bondar V.V., Sayegh L.S., Liu X.et al. .. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum. Mol. Genet. 2016; 25:5083&#x2013;5093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968355</ArticleId><ArticleId IdType="pubmed">28007900</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Emmett W., Fratta P., Isaacs A.M., Plagnol V.. Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med. Genet. 2017; 10:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446763</ArticleId><ArticleId IdType="pubmed">28549443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J.P., Pletnikova O., Troncoso J.C., Wong P.C.. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015; 349:650&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>De&#xa0;Santis R., Alfano V., de&#xa0;Turris V., Colantoni A., Santini L., Garone M.G., Antonacci G., Peruzzi G., Sudria-Lopez E., Wyler E.et al. .. Mutant FUS and ELAVL4 (HuD) aberrant crosstalk in amyotrophic lateral sclerosis. Cell Rep. 2019; 27:3818&#x2013;3831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613039</ArticleId><ArticleId IdType="pubmed">31242416</ArticleId></ArticleIdList></Reference><Reference><Citation>Gois A.M., Mendon&#xe7;a D.M.F., Freire M.A.M., Santos J.R.. In vitro and in vivo models of amyotrophic lateral sclerosis: an updated overview. Brain Res. Bull. 2020; 159:32&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">32247802</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D.. Rodent models of amyotrophic lateral sclerosis. Curr. Protoc. Pharmacol. 2015; 69:5.67.1&#x2013;5.67.21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Sivakumar P., Humphrey J., Lo K., Ricketts T., Oliveira H., Brito-Armas J.M., Kalmar B., Ule A., Yu Y.et al. .. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018; 37:e98684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Zhou H., Tong J., Chen H., Liu Y.J., Wang D., Wei X., Xia X.G.. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet. 2011; 7:e1002011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3048370</ArticleId><ArticleId IdType="pubmed">21408206</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeeck C., Deng Q., Dejesus-Hernandez M., Taylor G., Ceballos-Diaz C., Kocerha J., Golde T., Das P., Rademakers R., Dickson D.W.et al. .. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol. Neurodegener. 2012; 7:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519790</ArticleId><ArticleId IdType="pubmed">23046583</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van&#xa0;den&#xa0;Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017; 3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Scotter E.L., Nishimura A.L., Troakes C., Mitchell J.C., Kathe C., Urwin H., Manser C., Miller C.C., Hortob&#xe1;gyi T.et al. .. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 2013; 22:2676&#x2013;2688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteuuis G., Wong J.J.L., Bailey C.G., Schmitz U., Rasko J.E.J.. The changing paradigm of intron retention: regulation, ramifications and recipes. Nucleic Acids Res. 2019; 47:11497&#x2013;11513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145568</ArticleId><ArticleId IdType="pubmed">31724706</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunschweig U., Barbosa-Morais N.L., Pan Q., Nachman E.N., Alipanahi B., Gonatopoulos-Pournatzis T., Frey B., Irimia M., Blencowe B.J.. Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 2014; 24:1774&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4216919</ArticleId><ArticleId IdType="pubmed">25258385</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutz P.L., Bhutkar A., Sharp P.A.. Detained introns are a novel, widespread class of post-transcriptionally spliced introns. Genes Dev. 2015; 29:63&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281565</ArticleId><ArticleId IdType="pubmed">25561496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z., Zhu P., Shi H., Guo L., Zhang Q., Chen Y., Chen S., Zhang Z., Peng J., Chen J.. PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components. Nature. 2019; 568:259&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">30944473</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson M.F. Genetic paradox explained by nonsense. Nature. 2019; 568:179&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">30962551</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A. Translation dysregulation in neurodegenerative disorders. Proc. Natl Acad. Sci. USA. 2018; 115:12842&#x2013;12844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6304993</ArticleId><ArticleId IdType="pubmed">30504142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmkuhl E.M., Zarnescu D.C.. Lost in translation: evidence for protein synthesis deficits in ALS/FTD and related neurodegenerative diseases. Adv. Neurobiol. 2018; 20:283&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6530776</ArticleId><ArticleId IdType="pubmed">29916024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Jin H., Kasarskis E.J., Zhu H.. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl Acad. Sci. USA. 2018; 115:E11904&#x2013;E11913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe9;vigny M., Bourdeau&#xa0;Julien I., Venkatasubramani J.P., Hui J.B., Dutchak P.A., Sephton C.F.. FUS contributes to mTOR-dependent inhibition of translation. J. Biol. Chem. 2020; 295:18459&#x2013;18473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939483</ArticleId><ArticleId IdType="pubmed">33082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Gueroussov S., Weatheritt R.J., O&#x2019;Hanlon D., Lin Z.Y., Narula A., Gingras A.C., Blencowe B.J.. Regulatory expansion in mammals of multivalent hnRNP assemblies that globally control alternative splicing. Cell. 2017; 170:324&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">28709000</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho V., Mei Y., Sanny A., Chan S., Enders A., Bertram E.M., Tan A., Goodnow C.C., Andrews T.D.. The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA. Genome Biol. 2014; 15:R26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053824</ArticleId><ArticleId IdType="pubmed">24476532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutzi D., Campagne S., Schmidt R., Reber S., Mechtersheimer J., Gypas F., Schweingruber C., Colombo M., von&#xa0;Schroetter C., Loughlin F.E.et al. .. Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis. Nat. Commun. 2020; 11:6341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7733473</ArticleId><ArticleId IdType="pubmed">33311468</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T., Chen S., Yu Y., Yan B., Haertlein T.C., Carrasco M.A., Tapia J.C., Zhai B., Das R., Lalancette-Hebert M.et al. .. FUS&#x2013;SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2012; 2:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3483417</ArticleId><ArticleId IdType="pubmed">23022481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ustianenko D., Weyn-Vanhentenryck S.M., Zhang C.. Microexons: discovery, regulation, and function. Wiley Interdiscip. Rev. RNA. 2017; 8:e1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863539</ArticleId><ArticleId IdType="pubmed">28188674</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>